Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 3
1965 2
1966 4
1967 2
1968 1
1969 3
1970 5
1971 4
1972 7
1973 4
1974 7
1975 8
1976 5
1977 9
1978 4
1979 5
1980 4
1981 6
1982 5
1983 7
1984 6
1985 8
1986 10
1987 12
1988 7
1989 7
1990 8
1991 7
1992 1
1993 3
1994 3
1995 1
1996 1
1999 1
2000 2
2001 4
2002 2
2003 4
2004 2
2005 3
2006 2
2007 2
2008 6
2009 8
2010 2
2011 2
2012 3
2013 5
2014 4
2015 4
2016 6
2017 11
2018 8
2019 7
2020 7
2021 14
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

267 results
Results by year
Filters applied: . Clear all
Page 1
Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants.
Smith BD, Kaufman MD, Lu WP, Gupta A, Leary CB, Wise SC, Rutkoski TJ, Ahn YM, Al-Ani G, Bulfer SL, Caldwell TM, Chun L, Ensinger CL, Hood MM, McKinley A, Patt WC, Ruiz-Soto R, Su Y, Telikepalli H, Town A, Turner BA, Vogeti L, Vogeti S, Yates K, Janku F, Abdul Razak AR, Rosen O, Heinrich MC, Flynn DL. Smith BD, et al. Among authors: rosen o. Cancer Cell. 2019 May 13;35(5):738-751.e9. doi: 10.1016/j.ccell.2019.04.006. Cancer Cell. 2019. PMID: 31085175 Free article.
Improving admission medication reconciliation with pharmacists or pharmacy technicians in the emergency department: a randomised controlled trial.
Pevnick JM, Nguyen C, Jackevicius CA, Palmer KA, Shane R, Cook-Wiens G, Rogatko A, Bear M, Rosen O, Seki D, Doyle B, Desai A, Bell DS. Pevnick JM, et al. Among authors: rosen o. BMJ Qual Saf. 2018 Jul;27(7):512-520. doi: 10.1136/bmjqs-2017-006761. Epub 2017 Oct 6. BMJ Qual Saf. 2018. PMID: 28986515 Free PMC article. Clinical Trial.
Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib.
Janku F, Abdul Razak AR, Chi P, Heinrich MC, von Mehren M, Jones RL, Ganjoo K, Trent J, Gelderblom H, Somaiah N, Hu S, Rosen O, Su Y, Ruiz-Soto R, Gordon M, George S. Janku F, et al. Among authors: rosen o. J Clin Oncol. 2020 Oct 1;38(28):3294-3303. doi: 10.1200/JCO.20.00522. Epub 2020 Aug 17. J Clin Oncol. 2020. PMID: 32804590 Free PMC article. Clinical Trial.
Protein phosphorylation.
Rubin CS, Rosen OM. Rubin CS, et al. Among authors: rosen om. Annu Rev Biochem. 1975;44:831-87. doi: 10.1146/annurev.bi.44.070175.004151. Annu Rev Biochem. 1975. PMID: 166607 Review. No abstract available.
After insulin binds.
Rosen OM. Rosen OM. Science. 1987 Sep 18;237(4821):1452-8. doi: 10.1126/science.2442814. Science. 1987. PMID: 2442814 Review.
Optimizing dosing of oncology drugs.
Minasian L, Rosen O, Auclair D, Rahman A, Pazdur R, Schilsky RL. Minasian L, et al. Among authors: rosen o. Clin Pharmacol Ther. 2014 Nov;96(5):572-9. doi: 10.1038/clpt.2014.153. Epub 2014 Aug 8. Clin Pharmacol Ther. 2014. PMID: 25105705 Review.
Specific and Rapid SARS-CoV-2 Identification Based on LC-MS/MS Analysis.
Schuster O, Zvi A, Rosen O, Achdout H, Ben-Shmuel A, Shifman O, Yitzhaki S, Laskar O, Feldberg L. Schuster O, et al. Among authors: rosen o. ACS Omega. 2021 Jan 26;6(5):3525-3534. doi: 10.1021/acsomega.0c04691. eCollection 2021 Feb 9. ACS Omega. 2021. PMID: 33585737 Free PMC article.
267 results